DK446684A - Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme - Google Patents

Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme Download PDF

Info

Publication number
DK446684A
DK446684A DK446684A DK446684A DK446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A DK 446684 A DK446684 A DK 446684A
Authority
DK
Denmark
Prior art keywords
endotoxine
taxed
organism
pyridine
purified
Prior art date
Application number
DK446684A
Other languages
Danish (da)
English (en)
Other versions
DK446684D0 (da
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of DK446684D0 publication Critical patent/DK446684D0/da
Publication of DK446684A publication Critical patent/DK446684A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK446684A 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme DK446684A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
DK446684D0 DK446684D0 (da) 1984-09-19
DK446684A true DK446684A (da) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446684A DK446684A (da) 1983-09-23 1984-09-19 Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme

Country Status (23)

Country Link
US (1) US4663306A (fr)
JP (1) JPS60120817A (fr)
KR (1) KR870000843B1 (fr)
AT (1) AT385659B (fr)
AU (1) AU566234B2 (fr)
BE (1) BE900650A (fr)
CA (1) CA1244765A (fr)
CH (1) CH664897A5 (fr)
DE (1) DE3434766C2 (fr)
DK (1) DK446684A (fr)
ES (1) ES8608872A1 (fr)
FI (1) FI843716L (fr)
FR (1) FR2552326B1 (fr)
GB (1) GB2149301B (fr)
HU (1) HU192585B (fr)
IL (1) IL73034A (fr)
IN (1) IN157240B (fr)
IT (1) IT1179444B (fr)
NL (1) NL8402902A (fr)
NO (1) NO843776L (fr)
NZ (1) NZ209635A (fr)
SE (1) SE8404707L (fr)
ZA (1) ZA847405B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
CA2170142C (fr) * 1993-08-27 2010-05-25 Jose M. Wade Composition et methode pour stimuler le rendement de la reproduction
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
ATE227996T1 (de) 1997-08-05 2002-12-15 Bioniche Life Sciences Inc Zusammensetzung und verfahren zur regulierung von zellproliferation und zelltod
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
US7534443B1 (en) 1998-07-16 2009-05-19 Ichiro Azuma Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient
ES2340807T3 (es) * 1999-12-13 2010-06-09 Bioniche Life Sciences Inc. Oligonucleotidos sinteticos utiles terapeuticamente.
EP1250152B1 (fr) * 1999-12-28 2013-05-15 Bioniche Urology IP Inc. Composition synergique contenant de l'acide hyaluronique dans le traitement du cancer
PL360839A1 (en) * 2000-07-11 2004-09-20 Bayer Aktiengesellschaft Use of strains of the parapox ovis virus against organ fibrosis
US20050106155A1 (en) * 2002-03-05 2005-05-19 Tadao Ohno Solidified tissue immuoadjuvant
EP1547607A4 (fr) * 2002-08-02 2008-11-26 Dainippon Sumitomo Pharma Co Preparation d'un compose bacterien de squelette de paroi cellulaire
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
EP1741438A4 (fr) * 2004-04-22 2009-08-26 Dainippon Sumitomo Pharma Co Préparation pharmaceutique contenant un composant du squelette de la paroi de cellules bactériennes
CA2909221A1 (fr) 2013-04-18 2014-10-23 Immune Design Corp. Monotherapie par gla pour une utilisation dans le traitement du cancer
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
BR112016029581B1 (pt) 2014-06-17 2022-05-03 Crown Laboratories, Inc Propionibacterium acnes geneticamente modificada, composição e seus usos
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
CN116761582A (zh) 2020-06-23 2023-09-15 皇冠实验室有限公司 益生菌皮肤制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (fr) * 1972-06-20 1973-12-27
FR2269962B1 (fr) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (fr) * 1982-06-30 1986-06-24 John L. Cantrell Extrait de pyridine soluble provenant de microorganismes
CA1209504A (fr) * 1982-06-30 1986-08-12 John L. Cantrell Extrait de microorganisme soluble dans la pyridine
CA1206416A (fr) * 1982-06-30 1986-06-24 John L. Cantrell Extrait de pyridine soluble provenant de microorganismes

Also Published As

Publication number Publication date
HU192585B (en) 1987-06-29
FI843716A0 (fi) 1984-09-21
JPS60120817A (ja) 1985-06-28
NL8402902A (nl) 1985-04-16
ES536167A0 (es) 1986-07-16
DE3434766A1 (de) 1986-04-30
FR2552326A1 (fr) 1985-03-29
DK446684D0 (da) 1984-09-19
CH664897A5 (de) 1988-04-15
GB2149301A (en) 1985-06-12
IN157240B (fr) 1986-02-15
SE8404707D0 (sv) 1984-09-20
NO843776L (no) 1985-03-25
IL73034A (en) 1988-11-15
ES8608872A1 (es) 1986-07-16
NZ209635A (en) 1989-01-27
JPS6254775B2 (fr) 1987-11-17
GB2149301B (en) 1988-06-22
DE3434766C2 (de) 1987-05-14
ZA847405B (en) 1985-05-29
KR850002404A (ko) 1985-05-13
IT1179444B (it) 1987-09-16
FR2552326B1 (fr) 1988-05-13
KR870000843B1 (ko) 1987-04-25
GB8423993D0 (en) 1984-10-31
US4663306A (en) 1987-05-05
AT385659B (de) 1988-05-10
BE900650A (fr) 1985-03-21
FI843716L (fi) 1985-03-24
AU3340084A (en) 1985-03-28
IT8448894A0 (it) 1984-09-24
AU566234B2 (en) 1987-10-15
ATA302384A (de) 1987-10-15
HUT35521A (en) 1985-07-29
SE8404707L (sv) 1985-03-24
CA1244765A (fr) 1988-11-15

Similar Documents

Publication Publication Date Title
DK446684D0 (da) Farmaceutisk middel indeholdende et renset, afgiftet endotoksin i kombination med en pyridinoploeselig ekstrakt af en mikroorganisme
NO166518C (no) Stol med vektsavhengig tilbakestillingskraft for rygglenet
DK569784D0 (da) Farmaceutisk baeremedium med forsinket virkning
IL71967A (en) Drug administration composition
SE8801813D0 (sv) Pharmaceutical composition
FI862490A0 (fi) Flytande detergent komposition med foerbaettrad fysisk stabilitet foer diskmaskinen.
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
KR890701101A (ko) 제약학적 조성물
DK408788D0 (da) Fremstilling af terapeutiske ringe
FI821240A0 (fi) Med dubbelmod fungerande maetaravlaesningsanordning
DK529885D0 (da) Farmaceutiske kapsler med langvarig frigivelse
DK683987D0 (da) Topisk farmaceutisk praeparat til anvendelse i form af tape
PH21029A (en) Benzene derivatives, pharmaceutical compositions and method of use thereof
DK49488D0 (da) Anaestesi-praeparat
FI822670A0 (fi) Ergopeptinderivat, foerfaranden foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner och deras anvaendning vid terapeutisk behandling
IT1182061B (it) Derivati di amminofenolo, procedimento per prepararli e composizione farmaceutica che li contiene
DK369385A (da) Middel til behandling af schizofreni
IT8519385A0 (it) Composizione farmaceutica
DE3673136D1 (de) Polycarbonatzusammensetzung.
IL77565A (en) Polycyclic salts,their manufacture and pharmaceutical compositions containing them
IL79120A0 (en) Glycerol derivatives,their manufacture and pharmaceutical compositions containing them
FI853228L (fi) Nya -butyrolaktamer, deras farmaceutiskt aktiva kompositioner, foerfaranden foer deras framstaellning och deras anvaendning som laekemedel.
DK620989D0 (da) Anvendelse af et prostaglandin af e-typen i kombination med cyclosporin til fremstilling af et farmaceutisk praeparat
IT1181736B (it) Derivati di imidazopiridazina,composizione farmaceutica che li contiene e procedimento per prepararli
SE8400086D0 (sv) Farmaceutisk komposition

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment